Mediation analysis has been a popular framework for elucidating the mediating mechanism of the exposure effect on the outcome. Previous literature in causal mediation primarily focused on the classical settings with univariate exposure and univariate mediator, with recent growing interests in high dimensional mediator. In this paper, we study the mediation model with high dimensional exposure and high dimensional mediator, and introduce two procedures for mediator selection, MedFix and MedMix. MedFix is our new application of adaptive lasso with one additional tuning parameter. MedMix is a novel mediation model based on high dimensional linear mixed model, for which we also develop a new variable selection algorithm. Our study is motivated by the causal gene identification problem, where causal genes are defined as the genes that mediate the genetic effect. For this problem, the genetic variants are the high dimensional exposure, the gene expressions the high dimensional mediator, and the phenotype of interest the outcome. We evaluate the proposed methods using a mouse f2 dataset for diabetes study, and extensive real data driven simulations. We show that the mixed model based approach leads to higher accuracy in mediator selection and mediation effect size estimation, and is more reproducible across independent measurements of the response and more robust against model misspecification. The source R code will be made available on Github https://github.com/QiZhangStat/highMed upon the publication of this paper.
Introduction
Mediation analysis is a type of causal inference investigating the effect of certain exposures (Z) on an outcome (Y , Figure 1a ). It assumes a hypothesized causal chain in which all or a part of the exposure effect on the outcome may be attributed to its effect on some mediators (M) which in turns influence the outcome (indirect effect). These variables could be also influenced by some observed confounders (X). Mediation analysis was originated in social science (Baron and Kenny, 1986; MacKinnon, 2012) , and has been widely used in many applications.
The classical mediation analysis focuses on the case of univariate exposure and univariate mediator. The statistical causal inference literature has made tremendous progress in the estimation, testing and understanding of the mediation effect in such settings (Baron and Kenny, 1986; MacKinnon, 2012; VanderWeele, 2011 VanderWeele, , 2015 . Mediation models with multiple mediators or multiple exposures have also been studied. For example, VanderWeele and Vansteelandt (2014) proposed two analytic approaches for multiple mediators. Huang et al. (2014) studied the joint analysis of the phenotype, the expression of a gene and the SNPs using mediation framework with the gene expression as the univariate mediator and the SNPs within the gene as the low-dimensional multivariate exposure. Recently, models with high dimensional mediator have began to draw attention. Huang and Pan (2016) proposed a significance test for the effect of high dimensional mediator. Chén et al. (2017) and Zhao et al. (2018) proposed PCA-like concepts for summarizing the effects of high dimensional mediators in brain imaging studies. Zhang et al. (2016) and Sohn et al. (2019) studied the sparse estimation and testing of the high dimensional mediators for univariate exposure. The focus of this paper is the sparse estimation and evaluation of high dimensional mediator effects with high dimensional exposure ( Figure 1b ), which is different from all above. One motivating example is the causal gene identification problem. How the genetic variants influence the phenotypes, and what molecular mechanism mediates such effects are the central questions in genomics. Along this direction, researchers have proposed numerous methods for identifying the causal variant at SNP level (Kichaev et al., 2014) or the causal gene at transcriptomic level (Huang and Pan, 2016; Gamazon et al., 2015) . We focus on the latter problem in the natural genetic context. Specifically, we are interested in finding genes directly involved in the transcriptomic pathway from genetic variants to phenotype. Mediation models have been applied to this problem, most of which modeled one gene at a time (Zhu et al., 2016; Barfield et al., 2017) , or only considered univariate exposure (Huang and Pan, 2016; Zhang et al., 2016; Sohn et al., 2019) .
In this paper, we study the mediation analysis with high dimensional mediator and high dimensional exposure. In particular, we are interested in mediator selection and evaluating the effect of the selected mediators. We propose two regularized regression based approaches for this high dimensional mediator selection problem, and develop relevant statistical tests for causal effects and measures of the mediation effect size. The first proposal is a new application of adaptive lasso (Zou, 2006) after modification under the conventional fixed effect regression framework for mediation analysis. The second approach is a novel method based on high dimensional linear mixed model. This proposal treats the direct effect as random effect, which reduces the model complexity and improves robustness.
The rest of the paper is organized as follows. In Section 2, we start with the model setup for the mediation analysis with high dimensional mediator and high dimensional exposure, and introduce a new measure of mediation effect adapted for high dimensional exposure. In Section 3, we proceed to our two proposed procedures , including a new variable selection algorithm for high dimensional linear mixed model. In Section 4.1, we apply the proposed methods to causal gene identification from an f2 mouse dataset for diabetes study. In Section 4.2, we evaluate the two frameworks using extensive data driven simulations. We conclude in Section 5 with discussions and future work.
2 Causal Mediation Model with High Dimensinal Exposure and Mediator Candidates population under investigation. We use the variance of TE, NDE and NIE in (2) over the randomness of z as the population-level measures of effect sizes, and refer to them as the variance total effect (VTE), the variance direct effect (VDE) and the variance indirect effect (VIE). It immediately follows that
Then we define the proportion of mediation effect simply as the Proportion of the Variance Mediated (PVM), i.e.,
We remark that VTE is not necessarily the sum of V IE and V DE due to the potential correlatedness of the estimated direct and the indirect effects.
Regression Frameworks for High Dimensional Mediation Analysis
With some abuse of notations, let Y denote the observed n× 1 vector of the response, Z the n× q exposure matrix, M the n × p potential mediator matrix, and X the n × s confounder matrix including the intercept. We assume that the columns of M and Z are centered and standardized, and potentially q, p ≫ n, but presumably s < n. In genetics, Z could be the genotype matrix, M the gene expression matrix, and X includes the baseline covariates such as gender and age. Using the above notations, model (1) could be estimated using the following linear regression framework
where M j is the jth column of matrix M , ǫ ∼ N (0, σ 2 I n ), and η j ∼ N (0, σ 2 j I n ). We will introduce two regression-based methods for mediation analysis with high dimensional exposure and mediators. Each procedure is consist of three steps: (a) parameter estimation by fitting the outcome model and mediator models separately, (b) causal effect testing, and (c) estimating P V M to measure the mediation effect.
MedFix: Fixed Effect Model for Mediation

Parameter Estimation
One naive solution of (5) is applying a sparse regression technique. For the mediator models, various sparse regression procedures can be applied directly, such as adaptive lasso. For the outcome model, the predictors are heterogeneous with M being continuous and Z being discrete, and it is unclear whether such heterogeneity will cause any bias in the joint sparse selection. Thus we propose to introduce an additional tuning parameter to adjust such heterogeneity. In detail, we minimize the objectivê
for the outcome model where
Here λ > 0 is the overall penalty tuning parameter, θ ∈ (0, 1) adjusts the regularization levels on the two data types, and the weight vectors w (γ) and w (β) are normalized separately to be summed to p and q, respectively. It can be reformulated as adaptive lasso. The mediator models can be solved by directly applying adaptive lasso. The variable weight vectors in all cases are based on the initial lasso estimates of the regression coefficients (See Supplementary Notes for details). We refer to this naive solution to (5) using existing sparse regression procedure as Mediation analysis via Fixed effect model (MedFix).
Causal Effect Testing
Next we will perform statistical tests for NIE, NDE, TE and the individual mediator effects N IE j 's. Letγ j and s 2 j be the estimated γ j and the associated variance, and letβ (nz) andB (nz) j be the subvectors of the non-zero elements of the estimates of β and B j by MedFix, respectively, and Σ (β) and Σ (Bj ) their corresponding estimated variances. The tests for the causal effects can be reformulated as tests on the regression coefficients, for which we will take advantage of the oracle property of adaptive lasso (Zou, 2006) . We remark that a similar testing strategy was used in Zhang et al. (2016) where the exposure was univariate, while we focus on high dimensional exposure in this paper.
Rejecting H 0,j : N IE j = 0 requires rejecting both of H 0,γj : γ j = 0 and H 0,Bj : B j = 0. Let P γj and P Bj be their p-values, respectively. We define the p-value for H 0,j as P med,j = min(1, P γj + P Bj ). For MedFix, P γj is given by a z-test as P γj = 2[1 − Φ(|γ j |/s j )] ifγ j = 0, and P γj = 1 otherwise. P Bj is from the χ 2 likelihood ratio test comparing the selected mediator model for M j and the corresponding reduced model with only X. Holm−Bonferroni method (Holm, 1979 ) is applied to P med,j for j ∈ {1 ≤ j ≤ p;γ j = 0} to adjust the multiplicity in mediator selection.
Testing NDE is equivalently to testing H 0,β : β = 0. We calculate its p-value from a χ 2 -test as
where F β is the cdf of a χ 2 distribution with degree of freedom= |β| 0 .
We reject H 0,med : N IE = 0 if any of H 0,j is rejected. Thus its p-value is defined as P med = min(P med,1 , . . . , P med,p ). We reject H 0,T E : T E = 0 if any of H 0,med and H 0,β is rejected, i.e., there is no total exposure effect if and only if there is neither direct effect nor indirect effect. Thus its p-value is given by P T E = min(P med , P β ).
P V M Estimation
LetB,β andγ be the estimates of the coefficients in (5). Since V ar(Z) can be estimated using
MedMix: Mixed Effect Model for Mediation
In (5), γ models the association between the mediators and the outcome, and β and B j 's model the association between the exposure and the outcome/mediators, respectively. The sparse assumptions on β and B j 's are crucial for the initial estimation step of MedFix, but not necessary for hypothesis testing, as H 0,β and H 0,Bj are hypotheses on the whole regression coefficient vectors instead of their individual elements. Thus an alternative strategy is to model the effects of Z in (5) as random effects to reduce the dimension of the parameter space in sparse selection, which lead to the following high dimensional linear mixed models
where ǫ ∼ N (0, σ 2 I n ), η j ∼ N (0, σ 2 j I n ) are noises, and u and v j for j = 1, . . . , p are all length n random genetic effect vectors such that u ∼ N (0, τ K(Z)) and
The formulation of (7) is inspired by the quantitative genetics literature where modeling the genotype-trait association as random effects has led to huge success (Hayes et al., 2009; Riedelsheimer et al., 2012) . In quantitative genetics, K(Z), the covariance matrix of the random effect, is the marker-based genetic relatedness matrix of the subjects (VanRaden, 2008; Endelman and Jannink, 2012) , and it could be as simple as q −1 ZZ T .
Parameter Estimation
For model (7), the mediator selection for the outcome model is related to fixed effect selection for high dimensional linear mixed model, which can be solved by minimizing the following penalized negative log-likelihood
where V = τ K(Z) + σ 2 I n . For this potentially non-convex problem, we propose a novel variable selection algorithm which we will discuss in Section 3.3. Together with the mediator equations in (7) fitted using conventional linear mixed model technique (e.g., R package rrBLUP, Endelman 2011), we term this mediation analysis procedure based on (7) as Mediation analysis via Mixed effect model (MedMix).
Causal Effect Testing
Causal effect testing for MedMix is similar to the workflow for MedFix, except the following differences. For testing the individual mediator effect, we replace H 0,Bj : B j = 0 with H 0,τj : τ j = 0, for which the p-value P τj is calculated using a SKAT-like score test . For testing NDE, we propose to test H 0,τ : τ = 0 with its p-value P τ given by a similar score test instead of testing H 0,β : β = 0. Consequently, the p-value for H 0,j is P med,j = min(1, P γj + P τj ), and the p-value for H 0,T E is P T E = min(P med , P τ ).
P V M Estimation
Letv j ,û andγ be the estimated random effects and the regression coefficients in (7). Note that in (7), v j and u replace ZB j and Zβ in (5). Define an n× p matrix Ψ = (v 1 , . . . ,v p ), the MedMix based estimates of the causal effects in (3) are
Ψγ +û 2 and P V M mix = V IE mix / V T E mix .
Fixed Effect Selection Algorithm for MedMix
In this section, we discuss our proposed novel fixed effect selection algorithm for high dimensional linear mixed model that was deployed by MedMix for the outcome model in (7). Fixed effects selection has been studied in the literature (Schelldorfer et al., 2011; Fan and Li, 2012; Müller et al., 2013; Rohart et al., 2014; Xu et al., 2015; Ghosh and Thoresen, 2018; Pan and Shang, 2018; Tan et al., 2018) , most of which were on clustered data. For example, the pioneering work by Schelldorfer et al. (2011) proposed an L1 penalized estimation procedure for the fixed effect selection in high-dimensional linear mixed models. Focusing on the case of clustered data, they implemented their algorithm based on coordinate gradient descent for general random effect covariance structure, and distributed it as the R CRAN package lmmlasso. The model considered in this paper is different from the majority of the literature as there are no predefined clusters.
Fixed effect selection for linear mixed model naturally require the estimation of the variance components. Thus it is also related to the joint estimation of the regression coefficient and the noise level for linear model. Schelldorfer et al. (2011) can be regarded as such a procedure by maximizing the joint likelihood of all parameters. For iid noise, Zhang (2010, 2012) suggested that such one-stage maximum likelihood approach may cause bias in noise level estimation, and the proposed scaled lasso that iterates between estimating the regression coefficients and the noise level. Their procedure enjoys joint convexity, and the solution is almost always unique (Section 2 of Sun and Zhang 2012) . Motivated by their success, we adopt a similar alternating optimization strategy (Bezdek and Hathaway, 2003) with a scaled adaptive lasso penalty
where w j 's are the weights of the variables scaled to be summed to p. Consider the objective function (8), with V = τ K(Z) + σ 2 I n and the scaled adaptive lasso penalty (9). Suppose K(Z) is full-rank, and let its eigen decomposition be U DU
Reparametrize the above loss function by defining
It is jointly convex when d i 's are all 0, corresponding to the case with iid noise as for the original scaled lasso. However, when the noise are correlated as in the linear mixed model under consideration, the joint convexity of this objective function depends on the parameters, the data and d i 's in a complicated way. Thus the direct optimization of (11) is not guaranteed to reach a local minimum, even though using a coordinate gradient descent assures the convergence to a stationary point (Schelldorfer et al., 2011) . In fact, (11) is the sum of a concave function (the last term) and a convex function (the sum of the others), for which a concave-convex procedure (CCCP, Yuille and Rangarajan 2003) can be applied. Consider an objective Q(x) = Q vex (x) + Q cav (x) where Q vex (x) and Q cav (x) are a convex and a concave function, respectively. Let ▽Q cav (x) = ∂Q ∂x (x), and x (t) be the current estimate of x, then
) is a convex tight upper bound of Q(x). CCCP minimizes this upper bound in each iteration, and eventually converges to a local minimum of the original objective. It has been used in the literature for implementing SCAD (Fan and Li, 2001; Kim et al., 2008) .
For our algorithm, let (α (t) ,γ (t) , ρ (t) , δ (t) ) be a current estimate of (α,γ, ρ, δ), a tight upper bound of (11) is
In each iteration, we minimize this upper bound by alternatively updates the regression coefficients and the variance components related parameters.
Results
MedFix has two tuning parameters (λ, θ). When θ = 0.5, the penalty on the two data types in the outcome model of (5) are the same, and λ can be determined by minimizing BIC. We call this version of MedFix MedFix 0.5 . Alternatively, (λ, θ) can be jointly selected by BIC, which we term as MedFix BIC . MedMix has only one tuning parameter λ, and we determine it using BIC (Schelldorfer et al., 2011) . The random effect covariance matrix K(Z) can be modeled in many ways. Since our application is in genetics, we deploy two estimates of the genetic relatedness matrix, the original proposal (VanRaden, 2008) and a shrinkage estimate (Endelman and Jannink, 2012) . MedMix with these two types of covariance matrix for the random effect are referred to as MedMix linear and MedMix shrink , respectively. We will compare these four protocols in real data analysis and data-driven simulations. Throughout this paper, we set the significance level for mediator selection at 0.1.
Evaluation based on Real Data
We analyze a mouse f2 cross data for diabetes study Tu et al., 2012; Tian et al., 2015) . This dataset include the genotype captured by SNP array with 2057 markers, microarray-based gene expression with about 40k probes from six tissues, and various clinical phenotypes. The phenotypes we used as outcome are the plasma insulin level at 10 weeks before sacrifice. We are interested in identifying potential causal genes for insulin level. Since insulin is secreted from islet, we use the islet gene expression as the candidate mediator, and genotype as the exposure. We use gender as a covariate in all mediator models and outcome models. There are 491 mice with all three data types. One unique feature of this dataset is that it includes the following three independent measures of plasma insulin at 10 week which we will refer to as IA, IB, and IC:
IA : "INSULIN (ng/ml) 10 wk" from lipomics measure, the primary insulin measurement.
IB : "insulin 10 wk" from lipomics, a reproduced measurement IC : "Insulin (uIU/mL)" from RBM panel, a measurement using a different technology.
This enables us to compare methods based on the reproducibility of the analysis results across these phenotypes representing the independent measures of biologically identical signal, in the absence of "grand truth" in real data. We do not filter the genotype markers, but do screen the microarray probes, and only keep those share QTL and have reasonable correlations (|corr| ≥ 0.05) with the outcome (See Supplementary Notes for details of data preprocessing). We primarily focus on the accuracy and reproducibility in mediator selection and PVM estimation in the main paper, and the testing results on NIE, NDE and TE are in Supplementary Table 2.
MedMix tend to select more relevant mediators.
Since there is no well-established "grand truth" of causal genes for insulin, we use the known biological annotations as a proxy for evaluating the causal gene identification accuracy. For each gene, we record whether or not it is involved in a Gene Ontology (GO) term (Consortium, 2004) , KEGG pathway (Kanehisa and Goto, 2000) or Medical Subject Headings (MeSH) term (Lipscomb, 2000) for insulin, diabetes or islet/pancreas function. In Table 1 , we present the numbers of the mediators selected for each insulin measure by each method, and how many of them belong to a relevant term. We remark that this is not an enrichment analysis, and it is only based on their presence or absence in relevant terms. We find that MedMix shrink has the highest proportion of selected mediators with such annotations for phenotypes IA and IC, MedFix 0.5 is the highest for IB.
MedMix yield more reproducible mediators and estimates of overall mediation effect size.
Since the three phenotypes measure the same biological signal, a good mediator selection procedure should output similar genes in these analyses. We refer to a mediator as "reproducible" if it Table 1 : Analysis of three independent measurements of insulin level before sacrifice. For the columns of # of selected mediator genes, the numbers in parenthesis are the number of genes known to be relevant to pancreas function and/or diabetes determined by their affilication to the relevant GO/KEGG/MeSH terms. In each column of IA, IB and IC, the method with the highest proportion of relevant genes is in boldface. The column Reproducible presents the number of mediators selected by at least two of the three phenotypes, and the total number of genes selected for any phenotype. (5) 13(4) 7/24 0.53 0.66 0.76 0.11
is selected in at least two of the three analysis, and find that MedMix shrink performs the best in terms of the ratio of the reproducible mediators and the mediator selected in any analysis, and MedFix BIC scores the second (Table 1) . We also calculate the variance of the estimated PVM's across the three phenotypes for each method, and find that MedFix BIC leads to very large variation, while the other three methods are comparable. Overall, we conclude that MedMix shrink yields the most reproducible results.
MedMix and MedFix can differentiate causal mediation effect and pleiotropy.
It is known that insulin is secreted by islet. Thus the islet gene expressions are its most direct transcriptomic mediators. If the gene expressions from another tissue are used as the candidate mediator, the causal assumptions for mediation analysis would be violated. Any mediator genes selected in such analysis is most likely due to pleiotropy, spurious correlation or causal effect with reverse direction. It is difficult, if not impossible, for any quantitative model to automatically investigate the scientific appropriateness of the mediator candidates. Nevertheless, it is reasonable to expect a much smaller estimated PVM when irrelevant mediator candidates are used. We run MedFix and MedMix using gene expressions from each of the other five tissues (adipose, gastroc, hypothalamus, kidney and liver) as the candidate mediators, and calculate the corresponding PVM. If the output PVM from an irrelevant tissue is equal to or larger than the corresponding islet PVM, we label this case as a "failure" of separating the true and spurious causal mediation effects. We find that all methods output smaller PVMs in most cases when an irrelevant tissue is used as the potential mediators (Table 2 ). In particular, MedFix 0.5 and MedMix shrink fail less often than the other two. Most failures are for adipose and gastroc. It makes biological sense, because plasma insulin directly and indirectly (through glucose) regulates the expressions of a wide range of genes in adipose and gastroc (Ducluzeau et al., 2001; Elbein et al., 2011) . It reminds us that mediation analysis cannot distinguish the true causal mediation and the causal effect with reverse direction, which is a fundamental limitation of mediation models of all kinds.
Evaluation based on Simulations
We simulate data using a pipeline based on the above f2 mouse data analysis with IA as the outcome. The goal of our simulations is investigating the accuracy of mediator selection of MedFix and MedMix, and their robustness against model mis-specification.
Real Data Driven Simulation Model
We design a data-driven simulation model using the genotype, preprocessed islet gene expression and gender from the f2 mouse dataset as basis. We simulate the outcome Y and the mediators M using a hybrid of (5) and (7) controlled by a simulation parameter φ ∈ [0, 1]. When φ = 0, 1, (5) and (7) are the true models, respectively. When φ ∈ (0, 1), both MedMix and MedFix are misspecified. Thus this simulation model provides a common platform for investigating their robustness against model misspecification. The other two simulation parameters that we investigate are (h, g), the strength of the mediation effect and the direct effect, respectively. In our simulations, we assume there are 15 true mediators, and 15 fake mediators with mediatoroutcome link but without exposure-mediator link. The other ≈11k candidate mediators have no mediator-outcome link, regardless whether it is controlled by the exposure (See Supplementary Notes for details of the data-driven simulation model). We consider all 12 combinations of g = 1, 2, h = 1, 4 and φ = 0, 0.5, 1. For each scenario, we repeat the simulation for 40 replicates. ( 1 , 1 , 0.5 ) ( 1 , 2 , 0.5 ) ( 4 , 1 , 0.5 ) ( 4 , 2 , 0.5 ) MedFix 0.5 3.1 , 0.4 4.1 , 2 2.5 , 0.1 4.1 , 0.2 MedFix BIC 3.5 , 0.3 2.8 , 1.8 2.9 , 0.1 3.7 , 0.2 MedMix linear 0.3 , 1.5 0.6 , 1.8 0.6 , 1.2 0.1 , 1.6 MedMix shrink 0.4 , 1.5 0.3 , 1.8 0.5 , 1.2 0.1 , 1.6 (h, g, φ)
( 1 , 1 , 1 ) ( 1 , 2 , 1 ) ( 4 , 1 , 1 ) ( 4 , 2 , 1 ) MedFix 0.5 3.2 , 1.4 3 , 6.1 3.9 , 0.2 3.9 , 0.4 MedFix BIC 3.3 , 1.3 3.2 , 6 2.9 , 0. We compare the mediator selection accuracy using the simulated data (Table 3) , and find that in most of cases, MedMix models yield less false positives than MedFix methods with a slight increase in false negatives. The overall mediator selection errors (the sum of false positives and false negatives) for MedMix are almost always smaller than those for MedFix. In detail, when φ = 0, the simulation model is the same as the model underlying MedFix (5), and MedMix is mis-specified. However, MedFix and MedMix have comparable overall mediator selection errors. In contrast, when φ = 1 and the MedMix model (7) is the true model, MedMix clearly lead to less errors in all settings. When φ = 0.5, neither (5) nor (7) is the true model, and both of MedFix and MedMix are misspecified. In these cases, MedMix also perform better than MedFix in all scenarios. We further compare their variable selection accuracy for the outcome models (identifying nonzero elements of γ) without any significance tests, and observe similar advantage of MedMix (Supplementary Table 3 ). These results suggest that MedMix yields more accurate results than MedFix in a wider range of settings, and is more robust against model misspecification.
Discussion
In this paper, we study the mediation analysis with high dimensional candidate mediator and high dimensional exposure, and its application to causal gene detection. We develop two procedures for mediator selection and their associated causal effect tests and mediation effect measure.
MedFix is an application of adaptive lasso with an additional tuning parameter for the outcome model balancing the penalties on the exposure and the mediator variables. MedMix is based on high dimensional linear mixed models, for which we develop a new fixed effect selection algorithm for the outcome model. In our data driven simulation studies, we show that MedMix lead to more accurate mediator selection, and are more robust against model misspecification. We apply these methods to causal gene identification from an f2 mouse dataset for diabetes study, and find that MedMix is more likely to select higher proportions of relevant genes, and yields more reproducible results in mediator selection and PVM estimation. We focus on mediator selection and the evaluation of the joint mediation effect of the selected mediators in this paper, and do not discuss the roles of the individual mediators. Due to the potential mediator-mediator interaction, quantifying such individual effects requires stronger assumptions, even when there are only a few mediators, and their order in the causal chain is known (Daniel et al., 2015) . Thus we leave it for future research. We do not consider the exposure-exposure interaction, exposure-mediator interaction or nonlinear causal effects neither. Generalizations along this direction could be made potentially by extending (5) to additive models or by modeling K(Z) in (7) with an appropriate kernel function (Morota and Gianola, 2014) . Another future work we will pursue is to extend the current framework to the joint analysis of multiple outcomes. In the context of causal gene identification, such high dimensional mediation framework for multiple phenotype will dissect the pleiotropy of the phenotyeps, and lead to refined phenotypical causal networks with genetic basis.
F2 mouse data preprocessing
Mediation effect implies the existence of the association between the response and the exposure, the mediator and the exposure, and the mediator and the response. We use these assumptions to filter genes that enter our analysis. We only keep genes that satisfies the following three criteria. (1) Islet expression shares QTL with the phenotype under investigation (lod score≥ 3).
(2) Islet expression correlates with the phenotype (|corr| ≥ 0.05). (3) Islet expression has larger correlation with the phenotype than the expression in the other five tissues. We design this filtering procedure using low thresholds with the hope of including as many genes as possible, and about 11k genes survive for each insulin measure. The QTL/eQTL information are from Dr. Attie Lab Diabetes Database (http://diabetes.wisc.edu).
Real Data Driven Simulation Model
We simulate the outcome Y and the mediators M using a hybrid of MedFix model (5) and the MedMix model (7), controlled by a simulation parameter φ ∈ [0, 1]. When φ = 0, 1, MedFix and MedMix are the true models, respectively. When φ ∈ (0, 1), both MedMix and MedFix are misspecified. Thus our simulation setting provides a common platform for investigating their robustness against model misspecification. The other two simulation parameters that we investigate are (h, g), the strength of the mediation effect and the direct effect, respectively.
In the following, we elaborate on our data-driven simulation model. In the f2 mouse data analysis of the phenotype IA as in this paper, 15 genes were selected with in the outcome model by all four methods under consideration. We will use them as the true mediators for the simulation model, and let S T ⊂ {1, . . . , p} to denote their indices. Let S F be another 15 indices evenly spaced between 1 to p which we will use as the set of fake mediators with non-zero regression coefficients in the outcome model, but no exposure-mediator link.
The following elements are fixed for simulations.
• Z: the 491 × 2057 normalized genotype matrix from the real data.
• X: the intercept and sex from the real data
. . , M p ) denote the mediator matrix for our simulation student. We set M j be the same as M j , the islet gene expression in the real data, for j / ∈ S T ∪ S F , i.e., the irrelevant genes.
• α = (1, 0.2) T • β 0 : a length 2057 sparse vector who has eight nonzero coordinates evenly spaced from 1 to 2057 with values (1, −1, 2, −2, 1, −1, 2, −2).
• γ 0 : a length p sparse vector, whose nonzero elements are in S T ∪ S F with values (1, −1, 2, −2, 1, −1, 2, −2, 1, −1, 2, −2, 1, −1, 2, −2, 1, −1, 2, −2, 1, −1, 2, −2, 1, −1, 2, −2, 1, −1).
• M (mix) j and M (f ix) j , the predicted values of M j in the real data analysis based on MedMix and MedFix, respectively, for j ∈ S T ,i.e,. ] . Note that in the real data analysis, the MedMix and MedFix tests on exposure-mediator link for these 15 genes all return small p-values. So it is also expected for the simulated true mediators.
For the fake mediators with no exposure-mediator link j ∈ S F , we first generate α j ∼ 0.5 · U nif (−3, −2) + 0.5 · U nif (2, 3), then simulate M j |α j ∼ N (Xα j , I n ) and finally normalize M j to M j so that it has the same mean and variance as M j , the expression of gene j in real data. We calculate the direct effect based on MedFix β = g · β 0 , and simulate the direct effect based on MedMix u ∼ N (0, τ u ZZ T ) where τ u = |β| 2 2 /(q − 1). This is to assure that u and Zβ, the direct effects based on MedMix and MedFix, respectively, to have similar effect size on the outcome.
Finally, let the mediator regression coefficient γ = h · γ 0 , and we simulate the outcome as Y = Xα + M γ + [φu + (1 − φ)Zβ] + ǫ where ǫ ∼ N (0, I n )
To summarize, there are three simulation parameters (h, g, φ) , representing the strengths of the mediation effect, direct effect and the mixing weight of the underlying model of MedMix in above simulation model. In particular, the use of mixing weight φ in the simulation model enable us to study the robustness of MedMix and MedFix against model misspecification. We consider all combinations of g = 1, 2, h = 1, 4 and φ = 0, 0.5, 1. For each scenario, we repeat the simulation for 40 replicates. MedFix BIC 1.6 × 10 2.2 × 10 −6
